Work

Clinical benefits with Fluticasone furoate/Umeclidinium/Vilanterol therapy for COPD: post hoc subgroup analysis of ELLITHE study

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa4321

Authors: Kai-Michael Beeh, Saskia Krüger

Institutions: Respiratory Research Institute, Berlin-Chemie AG (Germany)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404097311

Cites:

Cited by:

Related to: 10